Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![$mgnx Graphic](https://lunarcrush.com/gi/w:26/t:$mgnx.png) $mgnx

MGNX sees mixed signals as Barclays initiates coverage with an Overweight rating, but social activity and sentiment are down.

### About $mgnx
MacroGenics, Inc. (MGNX) is a biotechnology company.  

### Insights [#](/topic/$mgnx/insights)
- $mgnx engagements is up XXXXXX% from the previous week.
- $mgnx posts created is up XXX% from the previous week.

### Engagements: XXXXX [#](/topic/$mgnx/interactions)
---
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$mgnx/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$mgnx/time-series/interactions.tsv)  
**Current Value**: XXXXX  
**Daily Average**: XXXXX  
**1 Week**: XXXXX +320%  
**1 Month**: XXXXX -XX%  
**1-Year High**: XXXXXXX on 2025-06-04  
**1-Year Low**: XX on 2025-05-03  

| Social Network | X     |
| -------------- | -     |
| Engagements    | XXXXX |
  

  
  
### Mentions: XX [#](/topic/$mgnx/posts_active)
---
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$mgnx/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$mgnx/time-series/posts_active.tsv)  
**Current Value**: XX  
**Daily Average**: XX  
**1 Month**: XX -XX%  
**1-Year High**: XXX on 2025-06-27  
**1-Year Low**: X on 2025-09-26  

| Social Network | X  |
| -------------- | -  |
| Mentions       | XX |
  

  
  
### Creators: XX [#](/topic/$mgnx/contributors_active)
---
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$mgnx/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$mgnx/time-series/contributors_active.tsv)  
XX unique social accounts have posts mentioning $mgnx in the last XX hours which is up XX% from X in the previous XX hours
**Daily Average**: XX  
**1 Month**: X -XX%  
**1-Year High**: XXX on 2025-06-27  
**1-Year Low**: X on 2025-09-26  

The most influential creators that mention $mgnx in the last XX hours

| Creator                                          | Rank | Followers | Posts | Engagements |
| -------                                          | ---- | --------- | ----- | ----------- |
| [@bioinvestor24](/creator/twitter/bioinvestor24) | X    | XXXXX     | X     | XXXXX       |
| [@BAMBossie81](/creator/twitter/BAMBossie81)     | X    | XXX       | X     | XXX         |
| [@Biobeats99](/creator/twitter/Biobeats99)       | X    | XXX       | X     | XX          |

[View More](/list/creators/$mgnx/100)
  
  
### Sentiment: XX% [#](/topic/$mgnx/sentiment)
---
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$mgnx/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$mgnx/time-series/sentiment.tsv)  
**Current Value**: XX%  
**Daily Average**: XX%  
**1 Month**: XX% +33%  
**1-Year High**: XXX% on 2025-05-13  
**1-Year Low**: XX% on 2025-09-11  

**Most Supportive Themes**
- **Positive Analyst Coverage:** (10%) Barclays initiates coverage with an Overweight rating, potentially indicating a positive outlook.
  
**Most Critical Themes**
- **Bearish Sentiment:** (20%)  Despite the positive coverage, long-term bearish sentiment persists.
- **Declining Social Activity:** (70%)  Overall social activity is down, with engagements and mentions decreasing.
  
Network engagement breakdown:  
| Network | Positive | %   | Neutral | %   | Negative | %  |
| ------- | -------- | -   | ------- | -   | -------- | -  |
| X       | XXXXX    | XX% | XXX     | XX% | X        | X% |
|         |          |     |         |     |          |    |
| Total   | XXXXX    | XX% | XXX     | XX% | X        | X% |
  


**Top assets mentioned**
In the posts about $mgnx in the last XX hours

[Merus N.V. Common Shares (MRUS)](/topic/$mrus)
[Merck & Co., Inc. (MRK)](/topic/$mrk)
[ImmunityBio, Inc. Common Stock (IBRX)](/topic/$ibrx)
[Dawn Protocol (DAWN)](/topic/dawn-protocol)
[Gilead Sciences, Inc. (GILD)](/topic/gilead-sciences)
[Sarepta Therapeutics, Inc. (SRPT)](/topic/sarepta-therapeutics-inc)
[Sarepta Therapeutics, Inc. (SRPT)](/topic/$srpt)
[Iovance Biotherapeutics, Inc. Common Stock (IOVA)](/topic/$iova)
[Sanofi (SNY)](/topic/sanofi)
[Bristol-Myers Squibb Co (BMY)](/topic/$bmy)

**Top topics mentioned**
In the posts about $mgnx in the last XX hours

[stocks healthcare](/topic/stocks-healthcare), [$mrus](/topic/$mrus), [investment](/topic/investment), [$mrk](/topic/$mrk), [$ibrx](/topic/$ibrx), [coins nft](/topic/coins-nft), [dawn protocol](/topic/dawn-protocol), [coins defi](/topic/coins-defi), [telegram](/topic/telegram), [$rcus](/topic/$rcus), [gilead sciences](/topic/gilead-sciences), [sarepta therapeutics inc](/topic/sarepta-therapeutics-inc), [$srpt](/topic/$srpt), [$iova](/topic/$iova), [fluffy](/topic/fluffy), [sanofi](/topic/sanofi), [$bmy](/topic/$bmy), [$bmrn](/topic/$bmrn), [bank of america](/topic/bank-of-america), [$ewtx](/topic/$ewtx), [$ltrpa](/topic/$ltrpa), [stocks consumer cyclical](/topic/stocks-consumer-cyclical), [stocks consumer defensive](/topic/stocks-consumer-defensive), [stocks financial services](/topic/stocks-financial-services), [exit](/topic/exit), [$sndx](/topic/$sndx), [banger](/topic/banger), [$kura](/topic/$kura), [$mnkd](/topic/$mnkd), [$myok](/topic/$myok), [$mreo](/topic/$mreo), [number of](/topic/number-of), [$sgmo](/topic/$sgmo), [sleeper](/topic/sleeper), [ticker](/topic/ticker), [$sln](/topic/$sln), [coins base ecosystem](/topic/coins-base-ecosystem), [$prqr](/topic/$prqr), [$sny](/topic/$sny), [tariffs](/topic/tariffs), [$abbv](/topic/$abbv), [rivals](/topic/rivals), [$bhvn](/topic/$bhvn), [$incy](/topic/$incy), [regeneron pharmaceuticals inc](/topic/regeneron-pharmaceuticals-inc), [$wve](/topic/$wve), [$rnac](/topic/$rnac), [$roiv](/topic/$roiv), [$glpg](/topic/$glpg), [$cytk](/topic/$cytk), [$dawn](/topic/$dawn), [$smmt](/topic/$smmt), [$mgtx](/topic/$mgtx), [$mgx](/topic/$mgx), [molina healthcare inc](/topic/molina-healthcare-inc)

### Top Social Posts [#](/topic/$mgnx/posts)
---
Top posts by engagements in the last XX hours

*Showing only X posts for non-authenticated requests. Use your API key in requests for full results.*

"$MRK phase X in platinum refractory OC today. Big improvement with pembro of X months OS when added to wkly taxol and avastin ( rivals FR ADC data $ABBV ) OS improvement much better than PFS as expected with PD1. Suggests to me adding other proven to work immune mechanisms such as Bispecific PD1-CTLA4 may enhance OS in several settings ( since $BMY used subtherapeutic ipilimumab in most of its trials ) Vs PD1 -VEGF that primarily improves PFS $SMMT with marginal impact on OS $MGNX Pd1 CTLA4 one of the most advanced of this class and in ovarian cancer trial. It could report positive PFS in"  
[X Link](https://x.com/bioinvestor24/status/1979586142745059736) [@bioinvestor24](/creator/x/bioinvestor24) 2025-10-18T16:31Z 4392 followers, 2406 engagements


"$MGNX delivered $SNY #TZIELD = Nat Com Vouch Q4 Data financial injection. Catalysts ahead. See shitty images. But in my mind - Tariffs. If I were a BP would I be building or buying a manufacturing facility Other picks for this Q: $WVE $ALT $ACHV $SGMO $SNDX $IOVA $SLS"  
[X Link](https://x.com/BAMBossie81/status/1979379430758736266) [@BAMBossie81](/creator/x/BAMBossie81) 2025-10-18T02:50Z XXX followers, XXX engagements


"@Soeren_Berlin Nuggets such as $MGNX might walk into XXX million milestone payment according to their last Q earnings filing - based on EU/China apporval MGNX sold to Sanofi Tzield - that just received a National Commissioners Voucher"  
[X Link](https://x.com/BAMBossie81/status/1979369272942993857) [@BAMBossie81](/creator/x/BAMBossie81) 2025-10-18T02:09Z XXX followers, XXX engagements


"Rare quality especially here on X. While I dont consider it fluffy I understand your perspective and we clearly have different levels of insight into the company and whats happening internally which makes your view legitimate from where you stand. Ill check out $MGNX and share my thoughts soon. In return you should take a look at $SLN and $PRQR two underrated darlings of mine with imminent catalysts. $SLN is basically the German version of Sangamo for RNAi weaker scientific evolution just as slow on deal progress but sitting on more cash"  
[X Link](https://x.com/Soeren_Berlin/status/1979365353525305583) [@Soeren_Berlin](/creator/x/Soeren_Berlin) 2025-10-18T01:54Z 1377 followers, XXX engagements

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

$mgnx Graphic $mgnx

MGNX sees mixed signals as Barclays initiates coverage with an Overweight rating, but social activity and sentiment are down.

About $mgnx

MacroGenics, Inc. (MGNX) is a biotechnology company.

Insights #

  • $mgnx engagements is up XXXXXX% from the previous week.
  • $mgnx posts created is up XXX% from the previous week.

Engagements: XXXXX #


Engagements Line Chart
Engagements 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XXXXX
1 Week: XXXXX +320%
1 Month: XXXXX -XX%
1-Year High: XXXXXXX on 2025-06-04
1-Year Low: XX on 2025-05-03

Social Network X
Engagements XXXXX

Mentions: XX #


Mentions Line Chart
Mentions 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XX
1 Month: XX -XX%
1-Year High: XXX on 2025-06-27
1-Year Low: X on 2025-09-26

Social Network X
Mentions XX

Creators: XX #


Creators Line Chart
Creators 24-Hour Time-Series Raw Data
XX unique social accounts have posts mentioning $mgnx in the last XX hours which is up XX% from X in the previous XX hours Daily Average: XX
1 Month: X -XX%
1-Year High: XXX on 2025-06-27
1-Year Low: X on 2025-09-26

The most influential creators that mention $mgnx in the last XX hours

Creator Rank Followers Posts Engagements
@bioinvestor24 X XXXXX X XXXXX
@BAMBossie81 X XXX X XXX
@Biobeats99 X XXX X XX

View More

Sentiment: XX% #


Sentiment Line Chart
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
1 Month: XX% +33%
1-Year High: XXX% on 2025-05-13
1-Year Low: XX% on 2025-09-11

Most Supportive Themes

  • Positive Analyst Coverage: (10%) Barclays initiates coverage with an Overweight rating, potentially indicating a positive outlook.

Most Critical Themes

  • Bearish Sentiment: (20%) Despite the positive coverage, long-term bearish sentiment persists.
  • Declining Social Activity: (70%) Overall social activity is down, with engagements and mentions decreasing.

Network engagement breakdown:

Network Positive % Neutral % Negative %
X XXXXX XX% XXX XX% X X%
Total XXXXX XX% XXX XX% X X%

Top assets mentioned In the posts about $mgnx in the last XX hours

Merus N.V. Common Shares (MRUS) Merck & Co., Inc. (MRK) ImmunityBio, Inc. Common Stock (IBRX) Dawn Protocol (DAWN) Gilead Sciences, Inc. (GILD) Sarepta Therapeutics, Inc. (SRPT) Sarepta Therapeutics, Inc. (SRPT) Iovance Biotherapeutics, Inc. Common Stock (IOVA) Sanofi (SNY) Bristol-Myers Squibb Co (BMY)

Top topics mentioned In the posts about $mgnx in the last XX hours

stocks healthcare, $mrus, investment, $mrk, $ibrx, coins nft, dawn protocol, coins defi, telegram, $rcus, gilead sciences, sarepta therapeutics inc, $srpt, $iova, fluffy, sanofi, $bmy, $bmrn, bank of america, $ewtx, $ltrpa, stocks consumer cyclical, stocks consumer defensive, stocks financial services, exit, $sndx, banger, $kura, $mnkd, $myok, $mreo, number of, $sgmo, sleeper, ticker, $sln, coins base ecosystem, $prqr, $sny, tariffs, $abbv, rivals, $bhvn, $incy, regeneron pharmaceuticals inc, $wve, $rnac, $roiv, $glpg, $cytk, $dawn, $smmt, $mgtx, $mgx, molina healthcare inc

Top Social Posts #


Top posts by engagements in the last XX hours

Showing only X posts for non-authenticated requests. Use your API key in requests for full results.

"$MRK phase X in platinum refractory OC today. Big improvement with pembro of X months OS when added to wkly taxol and avastin ( rivals FR ADC data $ABBV ) OS improvement much better than PFS as expected with PD1. Suggests to me adding other proven to work immune mechanisms such as Bispecific PD1-CTLA4 may enhance OS in several settings ( since $BMY used subtherapeutic ipilimumab in most of its trials ) Vs PD1 -VEGF that primarily improves PFS $SMMT with marginal impact on OS $MGNX Pd1 CTLA4 one of the most advanced of this class and in ovarian cancer trial. It could report positive PFS in"
X Link @bioinvestor24 2025-10-18T16:31Z 4392 followers, 2406 engagements

"$MGNX delivered $SNY #TZIELD = Nat Com Vouch Q4 Data financial injection. Catalysts ahead. See shitty images. But in my mind - Tariffs. If I were a BP would I be building or buying a manufacturing facility Other picks for this Q: $WVE $ALT $ACHV $SGMO $SNDX $IOVA $SLS"
X Link @BAMBossie81 2025-10-18T02:50Z XXX followers, XXX engagements

"@Soeren_Berlin Nuggets such as $MGNX might walk into XXX million milestone payment according to their last Q earnings filing - based on EU/China apporval MGNX sold to Sanofi Tzield - that just received a National Commissioners Voucher"
X Link @BAMBossie81 2025-10-18T02:09Z XXX followers, XXX engagements

"Rare quality especially here on X. While I dont consider it fluffy I understand your perspective and we clearly have different levels of insight into the company and whats happening internally which makes your view legitimate from where you stand. Ill check out $MGNX and share my thoughts soon. In return you should take a look at $SLN and $PRQR two underrated darlings of mine with imminent catalysts. $SLN is basically the German version of Sangamo for RNAi weaker scientific evolution just as slow on deal progress but sitting on more cash"
X Link @Soeren_Berlin 2025-10-18T01:54Z 1377 followers, XXX engagements

$mgnx
/topic/$mgnx